Le présent guide pratique de prise en charge du paludisme grave et de ses complications est la troisième révision et actualisation de l'ouvrage. Il est destiné prioritairement aux professionnels de santé; travaillant dans des hôpitaux ou des centres de santé disposant de structures d'hospital...isation et qui prennent en charge les malades atteints de paludisme grave. Ce manuel porte principalement sur les aspects pratiques de cette prise en charge, il se fonde sur les directives et les recommandations adoptées au titre de principes
standards de l'OMS.
more
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
4th edition. A manual for clinics, community health centers and district hospitals
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...rmulations on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
more
Handout presentations in PDF for illustrating lectures
Accessed May 2014
The technical note from the Global Task Force on Cholera Control (GTFCC) examines the risks and benefits of vaccinating pregnant women with WHO-prequalified oral cholera vaccines (OCVs) during mass vaccination campaigns. It highlights that three WHO-approved vaccines (Dukoral®, Shanchol™, and Euv...ichol®) offer sustained protection and a strong safety profile.
While these vaccines are not explicitly contraindicated for pregnant women, there is limited clinical data on their use during pregnancy. However, studies indicate that pregnant women with cholera face higher risks of fetal loss, stillbirth, and complications, especially if they experience severe dehydration. Some evidence suggests that vaccination can reduce cholera incidence in pregnant women and indirectly protect infants.
Although no controlled trials have focused on pregnant women, retrospective studies in Guinea and Zanzibar showed no significant increase in adverse pregnancy outcomes after OCV administration. The GTFCC concludes that the benefits of vaccination outweigh the risks, particularly in high-risk areas, and recommends including pregnant women in cholera vaccination campaigns while continuing to monitor safety data.
more
La 3ieme édition du nouveau mini-manuel.
Au cours des mois à venir COVID Reference publiera des mises à jour régulières.
This manual is about the basic nursing care - desinfection, cleaning, sterilization, nursing documentation, hygiene, surgical care and preparation and much more. This booklet has been prepared by the NED Volunteers Foundation.
Children's Health and the Environment WHO Training Package for the Health Sector World Health Organization
the Lancet : Published Online July 31, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61117-5
The aim of this publication is to provide practical guidance for the first responders who will respond during the first few hours to a radiological emergency and for the national officials who would support this early response. This publication provides guidance in the form of action guides, instruc...tions and data that can be easily applied by a State to build a basic capability to respond to a radiological emergency.
Also available in Arabic, French, Russian and Spanish: https://www-pub.iaea.org/books/IAEABooks/7606/Manual-for-First-Responders-to-a-Radiological-Emergency
more
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...leprosy infection. Furthermore, the relapse rate is very low, at about 1% over 5–10 years.
There is little M. leprae drug resistance in leprosy and few reports of multi-drug resistance (1, 2, 3,
4, 5, 6, 7, 8). An antibiotic treatment may take months or years to produce clinical improvement,
especially in patients with an initial high bacterial index (BI).
more